catechin has been researched along with beta-lactams in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatano, T; Ito, H; Mizushima, T; Shimizu, M; Shiota, S; Tsuchiya, T; Yoshida, T | 1 |
Hara, Y; Hu, ZQ; Okubo, S; Shimamura, T; Zhao, WH | 1 |
Asano, N; Hu, ZQ; Shimamura, T; Zhao, WH | 1 |
Basak, A; Chakraborty, A; Ghosh, SK; Roy, B | 1 |
Bernal, P; Hinds, J; Lemaire, S; Mobashery, S; Pinho, MG; Taylor, PW | 1 |
Foster, SJ; Rosado, H; Taylor, PW; Turner, RD | 1 |
Kwon, DH; Lee, S; Razqan, GS | 1 |
7 other study(ies) available for catechin and beta-lactams
Article | Year |
---|---|
Marked reduction in the minimum inhibitory concentration (MIC) of beta-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis).
Topics: Anti-Bacterial Agents; beta-Lactams; Catechin; Drug Synergism; Enzyme Inhibitors; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Tea | 1999 |
Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; beta-Lactams; Catechin; Cell Wall; Drug Synergism; Methicillin Resistance; Microbial Sensitivity Tests; Peptidoglycan; Staphylococcus aureus | 2001 |
Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catechin; Drug Synergism; Gram-Negative Bacteria; Microbial Sensitivity Tests | 2003 |
Design, synthesis and bioactivity of catechin/epicatechin and 2-azetidinone derived chimeric molecules.
Topics: Anti-Bacterial Agents; Azetidines; Catechin; Drug Design; Enzyme Inhibitors; Escherichia coli; Ribonuclease, Pancreatic | 2009 |
Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2.
Topics: Anisotropy; Anti-Bacterial Agents; beta-Lactams; Catechin; Cell Wall; Cytoplasm; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Lysine; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microscopy, Fluorescence; Oligonucleotide Array Sequence Analysis; Penicillin-Binding Proteins; Phosphatidylglycerols | 2010 |
Impact of the β-Lactam Resistance Modifier (-)-Epicatechin Gallate on the Non-Random Distribution of Phospholipids across the Cytoplasmic Membrane of Staphylococcus aureus.
Topics: beta-Lactams; Cardiolipins; Catechin; Cell Membrane; Lysine; Membrane Lipids; Methicillin-Resistant Staphylococcus aureus; Microscopy, Atomic Force; Peptidoglycan; Phenotype; Phosphatidylglycerols; Phospholipids | 2015 |
Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Catechin; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts | 2017 |